Previous Close
$
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$2.8 billion USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
Nasdaq
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazo...
Community
- 0 posts discussing
0
Watchers
0
Visitors